Other disciplines

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms

Morita, I., Oyama, H., Kiguchi, Y., Oguri, A., Fujimoto, N., Takeuchi, A., ... & Kobayashi, N. | Journal of Pharmaceutical and Biomedical Analysis | 21 July 2020

Ibogaine therapy for addiction: Consumer views from online fora

Barber, M., Gardner, J., Savic, M., & Carter, A. | Journal of Drug Policy | 18 July 2020

Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass

Petranker, R., Anderson, T., & Farb, N. | Frontiers in psychology | 10 July 2020

In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor

Pottie, E., Cannaert, A., & Stove, C. P | Archives of Toxicology | 5 July 2020

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. | Neuroscience & Biobehavioral Reviews | 15 March 2020

The Psychedelic Renaissance and Its Forensic Implications

Holoyda, B. | The journal of the American Academy of Psychiatry and the Law | 09 Mar 2020

The Psilocybin-Telomere Hypothesis: An Empirically Falsifiable Prediction Concerning the Beneficial Neuropsychopharmacological Effects of Psilocybin on Genetic Aging

Germann, C. B. | Medical hypotheses | 24 September 2019

Collective self-experimentation in patient-led research: How online health communities foster innovation

Kempner, J., & Bailey, J. | Social Science & Medicine | 11 June 2019

Psychedelic drugs-a new era in  psychiatry? 

Nutt, D. | Dialogues in clinical neuroscience | June 2019

Classic psychedelics: the special role of the visual system

Császár-Nagy, N., Kapócs, G., & Bókkon, I. | Reviews in the neurosciences | 2 April 2019

Psychedelics as anti-inflammatory agents

Flanagan, T. W., & Nichols, C. D. | International Review of Psychiatry | 13 August 2018

Gnosis Potency: DMT Breakthroughs and Paragnosis

St John, G. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Bubbling with Controversy: Legal Challenges for Ceremonial Ayahuasca Circles in the United States

Feeney, K., Labate, B. C., & Hudson, J. H. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Novel psychotherapeutics – a cautiously optimistic focus on Hallucinogens

Sherwood, A. M., & Prisinzano, T. E. | Expert Review of Clinical Pharmacology | 17 December 2017

A regulatory perspective on the evaluation of hallucinogen drugs for human use

Calderon, S. N., Hunt, J., & Klein, M. | Neuropharmacology | 24 November 2017

Regulation of human research with LSD in the United States (1949-1987)

Bonson, K. R. | Psychopharmacology | 17 November 2017

Horizontal gene cluster transfer increased hallucinogenic mushroom diversity

Reynolds, H. T., Vijayakumar, V., Gluck-Thaler, E., Korotkin, H. B., Matheny, P. B., & Slot, J. C. | bioRxiv | 16 August 2017

Peyote as Commodity: An Examination of Market Actors and Access Mechanisms

Feeney, K. | Human Organization | 1 March 2017

Ecstatic Landscapes: The Manifestation of Psychedelic Art

Krippner, S. | Journal of Humanistic Psychology | 20 October 2016

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society

Van Hagen, A. G. | BJPsych Bull | 11 August 2016

A Public-Health-Based Vision for the Management and Regulation of Psychedelics

Haden, M., Emerson, B., & Tupper, K. W. | Journal of Psychoactive Drugs | 18 July 2016

Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits

Zhang, M. W., & Ho, R. C. | Ethics & Behavior | 17 May 2016